NEW YORK (TheStreet) -- CHANGE IN RATINGS
Acorda (ACOR) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $30 price target. Company has limited upside earnings potential.
Altera (ALTR) downgraded at ThinkEquity from Buy to Hold, ThinkEquity said. Valuation call, based on a $40 price target.
Amgen (AMGN) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Stock is up 25% in the past two months. $75 price target.Bristow (BRS) rated new Buy at Dahlman. $54 price target. Company is less cyclical than its peers. Comerica (CMA) upgraded to buy at TheStreet Ratings. Continental Resources (CLR) downgraded at Jefferies to Hold from Buy, Jefferies said. Adjustments based on lower 2012 and long-term natural gas price deck. Concur Technologies (CNQR) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. Valuation call, based on a $52 price target. ConocoPhillips (COP) downgraded at UBS to Sell from Neutral, UBS said. $60 price target. Spin off highlights aggressive upstream valuation. Forest Oil (FST) downgraded at Jefferies to Hold from Buy, Jefferies said. $13 price target. Adjustments based on lower 2012 and long-term natural gas price deck. Janus Capital (JNS) upgraded at JP Morgan to Neutral, JP Morgan said. Company is leveraged to better equity returns. McMoran Exploration (MMR) downgraded at JP Morgan to Underweight, JP Morgan said. Davy Jones well results could prove disappointing. Procter & Gamble (PG) downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call. Research in Motion (RIMM) upgraded at Deutsche from Sell to Hold, Deutsche Bank said. $18 price target. New management's strategy will be key to survival. Sirius XM Radio (SIRI) downgraded at Morgan Stanley to Equal-weight, Morgan Stanley said. $2.30 price target. Stock is up 15% since pre-announcement and 2012 expectations may prove optimistic. Salix Pharmaceuticals (SLXP) downgraded at JMP from Outperform to Market Perform, JMP Securities said. Valuation call, as the stock is already pricing in a lot of good news. Suntrust Banks (STI) downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. Earnings recovery will likely take longer than 12 months. $19 price target. Viropharma (VPHM) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $35 price target. Stock is up 69% since October.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV